Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000373583 | SCV000329940 | pathogenic | not provided | 2023-02-05 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant expected to result in aberrant splicing with skipping of exon 5 (Coelho et al., 2012); This variant is associated with the following publications: (PMID: 27766264, 22922874, 33729671) |
Labcorp Genetics |
RCV000030861 | SCV001588728 | pathogenic | Methylmalonic acidemia with homocystinuria, type cblJ | 2020-08-02 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 5 of the ABCD4 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present in population databases (rs769364566, ExAC 0.001%). This variant has been observed in individual(s) with cblJ deficiency (PMID: 22922874). ClinVar contains an entry for this variant (Variation ID: 280107). Experimental studies have shown that this variant disrupts mRNA splicing (PMID: 22922874). Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ABCD4 are known to be pathogenic (PMID: 22922874). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000030861 | SCV000053536 | pathogenic | Methylmalonic acidemia with homocystinuria, type cblJ | 2012-10-01 | no assertion criteria provided | literature only |